SAFB
Basic information
Region (hg38): 19:5623034-5668478
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SAFB gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 37 | 38 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 0 | |||||
non coding ? | 0 | |||||
Total | 0 | 0 | 37 | 3 | 1 |
Variants in SAFB
This is a list of pathogenic ClinVar variants found in the SAFB region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-5623216-C-T | not specified | Uncertain significance (Dec 22, 2023) | ||
19-5623288-C-G | not specified | Uncertain significance (Aug 17, 2022) | ||
19-5626432-G-C | not specified | Uncertain significance (Mar 15, 2024) | ||
19-5641758-C-G | not specified | Uncertain significance (Dec 16, 2023) | ||
19-5641819-A-G | not specified | Uncertain significance (May 05, 2023) | ||
19-5641851-G-C | not specified | Uncertain significance (Dec 16, 2023) | ||
19-5641912-T-G | not specified | Uncertain significance (Jan 19, 2024) | ||
19-5641923-C-G | not specified | Uncertain significance (Dec 15, 2022) | ||
19-5645366-A-T | not specified | Uncertain significance (Aug 12, 2021) | ||
19-5648035-T-G | not specified | Uncertain significance (May 08, 2024) | ||
19-5649932-C-T | Benign (Jul 17, 2018) | |||
19-5651007-G-A | not specified | Uncertain significance (Mar 20, 2023) | ||
19-5653163-T-C | not specified | Uncertain significance (Mar 04, 2024) | ||
19-5654065-A-G | not specified | Likely benign (Nov 13, 2023) | ||
19-5654099-A-C | not specified | Uncertain significance (Oct 05, 2023) | ||
19-5654148-C-A | not specified | Uncertain significance (Feb 28, 2024) | ||
19-5654153-A-G | not specified | Uncertain significance (May 15, 2023) | ||
19-5654392-T-C | not specified | Uncertain significance (Feb 02, 2024) | ||
19-5654435-A-C | not specified | Uncertain significance (Nov 12, 2021) | ||
19-5654437-C-G | not specified | Uncertain significance (Dec 27, 2023) | ||
19-5657242-C-T | not specified | Likely benign (May 02, 2024) | ||
19-5657292-G-A | not specified | Uncertain significance (May 26, 2023) | ||
19-5657293-T-C | not specified | Uncertain significance (Jan 23, 2024) | ||
19-5657304-A-G | not specified | Uncertain significance (Dec 17, 2023) | ||
19-5661622-G-A | not specified | Uncertain significance (Dec 08, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SAFB | protein_coding | protein_coding | ENST00000588852 | 21 | 45444 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000193 | 125715 | 0 | 1 | 125716 | 0.00000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.14 | 383 | 521 | 0.736 | 0.0000359 | 6002 |
Missense in Polyphen | 78 | 137.23 | 0.5684 | 1753 | ||
Synonymous | -2.11 | 234 | 196 | 1.19 | 0.0000134 | 1717 |
Loss of Function | 5.98 | 2 | 45.6 | 0.0439 | 0.00000254 | 578 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000879 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Binds to scaffold/matrix attachment region (S/MAR) DNA and forms a molecular assembly point to allow the formation of a 'transcriptosomal' complex (consisting of SR proteins and RNA polymerase II) coupling transcription and RNA processing (By similarity). Can function as an estrogen receptor corepressor and can also bind to the HSP27 promoter and decrease its transcription. When associated with RBMX, binds to and stimulates transcription from the SREBF1 promoter (By similarity). Can inhibit cell proliferation. {ECO:0000250}.;
- Pathway
- Structural Pathway of Interleukin 1 (IL-1);Validated nuclear estrogen receptor alpha network
(Consensus)
Recessive Scores
- pRec
- 0.157
Intolerance Scores
- loftool
- 0.0204
- rvis_EVS
- -1.62
- rvis_percentile_EVS
- 2.93
Haploinsufficiency Scores
- pHI
- 0.207
- hipred
- Y
- hipred_score
- 0.743
- ghis
- 0.665
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.920
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Safb
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; respiratory system phenotype; skeleton phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- chromatin organization;regulation of transcription by RNA polymerase II;intracellular estrogen receptor signaling pathway;regulation of growth;hormone metabolic process;positive regulation of transcription by RNA polymerase II;regulation of mRNA processing
- Cellular component
- nucleus;nucleoplasm
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;chromatin binding;double-stranded DNA binding;RNA binding;protein binding;sequence-specific DNA binding